A Phase 1b Study of Talimogene Laherparepvec in Combination With Atezolizumab in Subjects with Triple Negative Breast Cancer and Colorectal Cancer with Liver Metastases

  • Markman, Ben (Primary Chief Investigator (PCI))
  • Body, Amy (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA Reference Number: HREC/16/MonH/119
SSA Reference Number: SSA/16/MonH/258
Monash Health HREC Ref: 16209A
Effective start/end date20/05/1919/05/24


  • clinical trial
  • treatment efficacy
  • colorectal cancer
  • breast cancer